by 252222pwpadmin | Feb 18, 2026 | Uncategorized
Nutide Ventures Participates in Sift Biosciences’ Oversubscribed $3.7M Pre-Seed Financing to Advance Next-Generation T-Cell Immunotherapy Platform Redwood City, CA, February 18, 2026 – Nutide Ventures today announced its participation in the recently closed $3.7...